Consolidated Statement of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
OPERATING ACTIVITIES
Net (loss) income	$ (207,000)	$ 3,130,000
Adjustments to reconcile net income to net cash provided by operating activities:
(Credit to) provision for credit losses	(200,000)	675,000
Depreciation	516,000	384,000
Amortization of intangible assets	120,000	132,000
Accretion of discounts, net	(321,000)	(683,000)
Origination of loans to be sold	(3,745,000)	(3,659,000)
Proceeds from loan sales	4,041,000	3,992,000
Gain on sale of loans	(296,000)	(333,000)
Share-based and deferred compensation	422,000	349,000
Bank-owned life insurance income	(310,000)	(225,000)
Loss (Gain) on sale of debt securities, available for sale	2,370,000	(13,000)
Change in accrued interest receivable and other assets	(217,000)	(2,356,000)
Change in accrued interest payable and other liabilities	(1,833,000)	(590,000)
Net cash provided by operating activities	340,000	803,000
Investment securities available for sale:
Proceeds from sales	1,847,000	513,000
Proceeds from calls and maturities		1,150,000
Proceeds from principal repayments	3,759,000	7,271,000
Purchases	(9,756,000)
Investment securities held to maturity
Proceeds from principal repayments	1,337,000	628,000
Purchases	(11,289,000)	(29,389,000)
Proceeds from redemptions of certificates of deposit with other banks	5,125,000	1,740,000
Purchase of restricted investment in bank stocks	(5,853,000)	(999,000)
Redemption of restricted investment in bank stocks	3,686,000	1,117,000
Increase in loans, net	(40,544,000)	(70,596,000)
Purchase of bank-owned life insurance	(5,000,000)
Purchase of premises and equipment	(65,000)	(3,010,000)
Net cash used in investing activities	(56,753,000)	(91,575,000)
FINANCING ACTIVITIES
Increase in deposits, net	88,070,000	130,708,000
Change in short-term borrowings, net	(21,039,000)	(18,175,000)
Proceeds from issuance of subordinated debt		20,000,000
Proceeds from other borrowings	75,000,000
Issuance of shares from exercise of stock options		120,000
Dividends paid	(2,435,000)	(1,475,000)
Net proceeds from issuance of common stock	9,980,000
Net cash provided by financing activities	149,576,000	131,178,000
Increase in cash and cash equivalents	93,163,000	40,406,000
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	30,011,000	22,590,000
CASH AND CASH EQUIVALENTS AT END OF PERIOD	123,174,000	62,996,000
SUPPLEMENTAL CASH FLOW DISCLOSURES
Interest	$ 11,296,000	1,926,000
Income taxes		$ 200,000